论文部分内容阅读
目的:对持续热灌注腹腔化疗(HIPC)在肠胃肿瘤中的应用效果进行探讨。方法:将65例在我院接受治疗的肠胃肿瘤患者分成两组,均接受了静脉化疗,基于此,33例的热灌注组接受HIPC,32例的传统组接受常规腹腔化疗,对照两组效果。结果:热灌注组总有效率是84.8%,相较于传统组的71.9%明显较高,P<0.05,两组不良反应对照则差异不突出,P>0.05。结论:对肠胃肿瘤实施治疗时,施予持续热灌注腹腔化疗可促进疗效的提升,使患者病情缓解。
Objective: To investigate the effect of continuous thermal perfusion intraperitoneal chemotherapy (HIPC) in gastrointestinal tumors. Methods: Sixty-five patients with gastrointestinal cancer who were treated in our hospital were divided into two groups and received intravenous chemotherapy. Based on this, 33 patients received HIPC, and 32 patients received conventional intraperitoneal chemotherapy. The control group . Results: The total effective rate of heat perfusion group was 84.8%, which was significantly higher than 71.9% of the traditional group (P <0.05). There was no significant difference in adverse reaction between the two groups (P> 0.05). Conclusion: In the treatment of gastrointestinal neoplasms, continuous intraperitoneal hyperthermic intraperitoneal chemotherapy can promote the curative effect and relieve the patient’s condition.